Emily O’Neill
Rhode Island Department of Health(US)Providence College(US)Brown University(US)St. Vincent's University Hospital(IE)Department of Health Services(NP)Lifespan(US)Department of Health Services(US)London School of Economics and Political Science(GB)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance, Obstructive Sleep Apnea Research, Geriatric Care and Nursing Homes, Computational Drug Discovery Methods
Most-Cited Works
- → T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.(1994)512 cited
- → Discovery and Characterization of Novel Tryptophan Hydroxylase Inhibitors That Selectively Inhibit Serotonin Synthesis in the Gastrointestinal Tract(2008)154 cited
- → Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders(2009)74 cited
- → Metformin is Associated with Decreased 30-Day Mortality Among Nursing Home Residents Infected with SARS-CoV2(2020)71 cited
- → Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes(2017)64 cited
- → Early Toxicology Signal Generation in the Mouse(2010)24 cited